Truepill CEO Sid Viswanathan.

Truepill

The DEA just put Truepill on notice that it may revoke its ability to fill controlled substances. The agency alleges that the pharmacy startup unlawfully dispensed stimulants used to treat ADHD. Truepill partnered with the mental-health startup Cerebral to send prescriptions to its patients. 

The US Drug Enforcement Administration just put Truepill on notice that it may revoke its ability to fill controlled substances, citing allegations that the online...

Continue Reading The DEA is alleging Truepill, Cerebral's former pharmacy partner, broke the law in filling prescriptions for highly regulated drugs